Carmen Capone1,2, Emmanuel Cognat1,2, Lamia Ghezali1,2, Céline Baron-Menguy1,2, Déborah Aubin1,2, Laurent Mesnard3,4, Heidi Stöhr5, Valérie Domenga-Denier1,2, Mark T Nelson6,7, Anne Joutel1,2. 1. Genetics and Pathogenesis of Cerebrovascular Diseases, Inserm, U1161 and Univ Paris Diderot, Sorbonne Paris Cité, UMRS 1161, F-75010, Paris, France. 2. DHU NeuroVasc, Sorbonne Paris Cité, Paris, France. 3. Rare and Common Kidney Diseases, Matrix Remodeling and Tissue Repair, Inserm U1155 and Pierre and Marie Curie University, Sorbonne Universities UMR-S 1155, F-75020, Paris, France. 4. Department of Emergency Nephrological and Renal Transplantation, Tenon Hospital, AP-HP, F-75020, Paris, France. 5. Institute of Human Genetics, University of Regensburg, Regensburg, Germany. 6. Department of Pharmacology, College of Medicine, University of Vermont, Burlington, VT. 7. Institute of Cardiovascular Sciences, University of Manchester, Manchester, United Kingdom.
Abstract
OBJECTIVE: CADASIL is a genetic paradigm of cerebral small vessel disease caused by NOTCH3 mutations that stereotypically lead to the extracellular deposition of NOTCH3 ectodomain (Notch3(ECD) ) on the vessels. TIMP3 and vitronectin are 2 extracellular matrix proteins that abnormally accumulate in Notch3(ECD) -containing deposits on brain vessels of mice and patients with CADASIL. Herein, we investigated whether increased levels of TIMP3 and vitronectin are responsible for aspects of CADASIL disease phenotypes. METHODS: Timp3 and vitronectin expression were genetically reduced in TgNotch3(R169C) mice, a well-established preclinical model of CADASIL. A mouse overexpressing human TIMP3 (TgBAC-TIMP3) was developed. Disease-related phenotypes, including cerebral blood flow (CBF) deficits, white matter lesions, and Notch3(ECD) deposition, were evaluated between 6 and 20 months of age. RESULTS: CBF responses to neural activity (functional hyperemia), topical application of vasodilators, and decreases in blood pressure (CBF autoregulation) were similarly reduced in TgNotch3(R169C) and TgBAC-TIMP3 mice, and myogenic responses of brain arteries were likewise attenuated. These defects were rescued in TgNotch3(R169C) mice by haploinsufficiency of Timp3, although the number of white matter lesions was unaffected. In contrast, haploinsufficiency or loss of vitronectin in TgNotch3(R169C) mice ameliorated white matter lesions, although CBF responses were unchanged. Amelioration of cerebrovascular reactivity or white matter lesions in these mice was not associated with reduced Notch3(ECD) deposition in brain vessels. INTERPRETATION: Elevated levels of TIMP3 and vitronectin, acting downstream of Notch3(ECD) deposition, play a role in CADASIL, producing divergent influences on early CBF deficits and later white matter lesions.
OBJECTIVE: CADASIL is a genetic paradigm of cerebral small vessel disease caused by NOTCH3 mutations that stereotypically lead to the extracellular deposition of NOTCH3 ectodomain (Notch3(ECD) ) on the vessels. TIMP3 and vitronectin are 2 extracellular matrix proteins that abnormally accumulate in Notch3(ECD) -containing deposits on brain vessels of mice and patients with CADASIL. Herein, we investigated whether increased levels of TIMP3 and vitronectin are responsible for aspects of CADASIL disease phenotypes. METHODS:Timp3 and vitronectin expression were genetically reduced in TgNotch3(R169C) mice, a well-established preclinical model of CADASIL. A mouse overexpressing humanTIMP3 (TgBAC-TIMP3) was developed. Disease-related phenotypes, including cerebral blood flow (CBF) deficits, white matter lesions, and Notch3(ECD) deposition, were evaluated between 6 and 20 months of age. RESULTS: CBF responses to neural activity (functional hyperemia), topical application of vasodilators, and decreases in blood pressure (CBF autoregulation) were similarly reduced in TgNotch3(R169C) and TgBAC-TIMP3mice, and myogenic responses of brain arteries were likewise attenuated. These defects were rescued in TgNotch3(R169C) mice by haploinsufficiency of Timp3, although the number of white matter lesions was unaffected. In contrast, haploinsufficiency or loss of vitronectin in TgNotch3(R169C) mice ameliorated white matter lesions, although CBF responses were unchanged. Amelioration of cerebrovascular reactivity or white matter lesions in these mice was not associated with reduced Notch3(ECD) deposition in brain vessels. INTERPRETATION: Elevated levels of TIMP3 and vitronectin, acting downstream of Notch3(ECD) deposition, play a role in CADASIL, producing divergent influences on early CBF deficits and later white matter lesions.
Authors: Carmen Capone; Giuseppe Faraco; Jeffrey R Peterson; Christal Coleman; Josef Anrather; Teresa A Milner; Virginia M Pickel; Robin L Davisson; Costantino Iadecola Journal: J Neurosci Date: 2012-04-04 Impact factor: 6.167
Authors: Andreas Janssen; Julia Hoellenriegel; Marton Fogarasi; Heinrich Schrewe; Mathias Seeliger; Ernst Tamm; Andreas Ohlmann; Christian Albrecht May; Bernhard H F Weber; Heidi Stöhr Journal: Invest Ophthalmol Vis Sci Date: 2008-04-11 Impact factor: 4.799
Authors: Kiyoshi Niwa; Ken Kazama; Linda Younkin; Steven G Younkin; George A Carlson; Costantino Iadecola Journal: Am J Physiol Heart Circ Physiol Date: 2002-07 Impact factor: 4.733
Authors: Soojin Kim; Ellen A A Nollen; Kazunori Kitagawa; Vytautas P Bindokas; Richard I Morimoto Journal: Nat Cell Biol Date: 2002-10 Impact factor: 28.213
Authors: Laura B Payne; Huaning Zhao; Carissa C James; Jordan Darden; David McGuire; Sarah Taylor; James W Smyth; John C Chappell Journal: Microcirculation Date: 2019-05-27 Impact factor: 2.628
Authors: Maximilian Böhm; David Y Chung; Carlos A Gómez; Tao Qin; Tsubasa Takizawa; Homa Sadeghian; Kazutaka Sugimoto; Sava Sakadžić; Mohammad A Yaseen; Cenk Ayata Journal: J Cereb Blood Flow Metab Date: 2019-05-07 Impact factor: 6.200
Authors: Rosalind Brown; Helene Benveniste; Sandra E Black; Serge Charpak; Martin Dichgans; Anne Joutel; Maiken Nedergaard; Kenneth J Smith; Berislav V Zlokovic; Joanna M Wardlaw Journal: Cardiovasc Res Date: 2018-09-01 Impact factor: 10.787
Authors: Karen Horsburgh; Joanna M Wardlaw; Tom van Agtmael; Stuart M Allan; Mike L J Ashford; Philip M Bath; Rosalind Brown; Jason Berwick; M Zameel Cader; Roxana O Carare; John B Davis; Jessica Duncombe; Tracy D Farr; Jill H Fowler; Jozien Goense; Alessandra Granata; Catherine N Hall; Atticus H Hainsworth; Adam Harvey; Cheryl A Hawkes; Anne Joutel; Rajesh N Kalaria; Patrick G Kehoe; Catherine B Lawrence; Andy Lockhart; Seth Love; Malcolm R Macleod; I Mhairi Macrae; Hugh S Markus; Chris McCabe; Barry W McColl; Paul J Meakin; Alyson Miller; Maiken Nedergaard; Michael O'Sullivan; Terry J Quinn; Rikesh Rajani; Lisa M Saksida; Colin Smith; Kenneth J Smith; Rhian M Touyz; Rebecca C Trueman; Tao Wang; Anna Williams; Steven C R Williams; Lorraine M Work Journal: Clin Sci (Lond) Date: 2018-04-30 Impact factor: 6.124